A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy

INTRODUCTION: Chronic hepatitis B (CHB) is a prevalent disease associated with high morbidity, mortality, and impact on health care costs. Antiviral therapy is aimed at reducing hepatitis B virus replication in order to limit progressive liver disease and improve the natural history of the disease....

Descripción completa

Detalles Bibliográficos
Autores principales: Colombo, Giorgio L, Gaeta, Giovanni B, Viganò, Mauro, Di Matteo, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169981/
https://www.ncbi.nlm.nih.gov/pubmed/21935331
http://dx.doi.org/10.2147/CEOR.S16655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169981/
https://www.ncbi.nlm.nih.gov/pubmed/21935331
http://dx.doi.org/10.2147/CEOR.S16655

Ejemplares similares